2021 Regional Affiliation Project in Si/Gun/Gu: 1.5 Billion KRW National Funding, 150 Million KRW Local Funding

(Gyeongnam Korean Medicine Anti-Aging Research Institute) Selected for Regional Industry Development Project Competition View original image

[Asia Economy Yeongnam Reporting Headquarters Reporter Park Saeyan] The Gyeongnam Korean Medicine Anti-Aging Research Foundation was finally selected on the 20th as the lead institution for the '2021 City/County/District Local Industry Promotion Project' promoted by the Ministry of SMEs and Startups.


The 'City/County/District Local Industry Promotion Project' is a project that supports 1.5 billion KRW in national funds and 150 million KRW in local funds over three years to create new added value based on specialized technologies or resources within the region.


Among the promising local industries, 'Korean Medicine Herbal Industry Advancement' was the only cultivation task selected in Gyeongnam.


The research institute plans to support companies related to the Korean medicine herbal industry in Sancheong-gun by developing new convergence products, providing package support for promising growth companies, technical support during product development, product certification and testing analysis, and efficacy verification of products and materials.


In particular, it plans to provide full support so that Korean medicine herbal companies can grow into star companies by combining customized support for small businesses with the institute’s research support.


Over three years, it is expected that the regional economy will be revitalized by supporting new product development and product upgrading for more than 30 Korean medicine herbal companies.



It is also expected to expand the industrial structure concentrated in the existing Donguibogam Village and establish a foundation for balanced development of the Korean medicine anti-aging industry.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing